Biotech Values

[Biowatch]

>>While NFLD claims their process can deal with known typical blood contaminants (HIV, prions, etc) there is no clinical proof. Without clinical proof of this claim the FDA will never let NFLD sell PolyHeme sourced from contaminated blood.<<

I think they would have a hard time recruiting patients for clinical trials using contaminated blood. They'd have to get it approved and with further proof of safety before they could begin designing clinical trials to test contaminated blood as a source.

Even the remote chance of passing on "mad cow" disease restricted the pool of eligible blood donors, eliminating anyone who lived in Great Britain or Europe for too long after a certain date.